In vitro combined activity of amphotericin B, caspofungin and voriconazole against clinical isolates of Trichosporon asahii
- 30 June 2010
- journal article
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 35 (6) , 550-552
- https://doi.org/10.1016/j.ijantimicag.2010.01.013
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- In vitro interaction of micafungin with conventional and new antifungals against clinical isolates of Trichosporon, Sporobolomyces and RhodotorulaJournal of Antimicrobial Chemotherapy, 2005
- Efficacy of Micafungin in Combination with Other Drugs in a Murine Model of Disseminated TrichosporonosisAntimicrobial Agents and Chemotherapy, 2005
- Infections due to emerging and uncommon medically important fungal pathogensClinical Microbiology & Infection, 2004
- Pathogenesis of Trichosporon asahii and Strategies for Infectious Control of Disseminated TrichosporonosisJapanese journal of medical mycology, 2003
- Trichosporon asahii,a Non‐CandidaYeast That Caused Fatal Septic Shock in a Patient without Cancer or NeutropeniaClinical Infectious Diseases, 2001
- Trichosporon species infection in bone marrow transplanted patientsDiagnostic Microbiology and Infectious Disease, 2001
- Uncommon opportunistic fungi: new nosocomial threatsClinical Microbiology & Infection, 2001
- Trichosporon beigelii infection: experience in a regional burn centerBurns, 2000
- Emerging fungal pathogens: evolving challenges to immunocompromised patients for the twenty‐first centuryTransplant Infectious Disease, 1999
- Efficacy of Amphotericin B and Azoles Alone and in Combination against Disseminated Trichosporonosis in Neutropenic MiceChemotherapy, 1997